Is Genentech losing its zest for innovation? Genentech has long been known for innovation, but that reputation has been questioned in the wake of multiple rounds of layoffs and the company’s ...

For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place where researchers have developed new therapies in-house and published ...

Aviv Regev, executive vice president and head of Genentech Research & Early Development (gRED) NVIDIA’s push into the life sciences sector has been rewarded by a wide-ranging deal with Roche’s ...

All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, ...

Roche’s Genentech unit has looked internally for its new chief executive, appointing Ashley Magargee to the role following the departure of Alexander Hardy last month. Magargee has been serving ...

Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...

In our quest to find the best website builders, we sought the most user-friendly platforms with powerful features. We believe a website builder should be intuitive for beginners yet robust enough ...

Leverage the power of AI to build a great website in record time. Using one of the best AI website builders can help you build a better website easier and faster than ever before. Artificial ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Company welcomes additional late-stage expertise as it prepares for amezalpat pivotal studyBRISBANE, Calif., Sept. 18, 2024 ...